The first Indo/Russian joint venture in the field of pharmaceuticals was established during the recent visit to Moscow of India's Commerce Minister, Mr P Chidambaram. The JV is between Dr Reddy's Laboratories of Hyderbad and Russia's Ao-Biomed, a well-known pharmaceutical factory in Russia, with several decades of experience in the manufacture of vaccines, immunologicals and other health care products.
To be called Reddy-Biomed, the JV will manufacture antibiotics and other formulations for the Russian and international markets. During Mr Chidambaram's visit, both countries agreed to set up a sub-group on pharmaceuticals under the working group on Trade and Economic Cooperation, which was decided on in discussions with Russia's Minister of Health, Mr E Nachaev.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze